Targeted IL-2 immunocytokine therapy directed at oncofetal chondroitin sulfate for pediatric solid tumors

Key Points

• This research investigates the efficacy of targeted IL-2 immunocytokine therapy in treating pediatric solid tumors.
• Trial focuses on pediatric patients with solid tumors.
• Involves administration of IL-2 immunocytokine directed at oncofetal chondroitin sulfate.
• Results show a significant reduction in tumor size with IL-2 therapy, indicating potential effectiveness.
• Improvement in patient outcomes related to tumor remission.

Abstract